02/07/2025
https://www.facebook.com/share/p/172jwAdgoQ/?mibextid=wwXIfr
Joe Tippens was given months to live. But after taking an anti-parasitic drug, PET scans revealed no detectable cancer cells. His cancer was gone.
In 2016, Tippens was diagnosed with terminal small-cell lung cancer and given a grim prognosis of mere months of survival. Desperate for alternatives, he began taking fenbendazole—a veterinary deworming medication typically used for dogs—in combination with supplements including Theracurmin (a concentrated turmeric extract) and CBD oil.
Remarkably, within three months of starting this unconventional protocol, his medical scans showed no trace of cancer. While it's impossible to definitively establish whether this dramatic recovery resulted from his self-directed treatment regimen, Tippens's extraordinary case rapidly gained attention throughout online patient communities, sparking widespread interest among both cancer patients and healthcare providers.
Emerging anecdotal evidence and preliminary laboratory studies now indicate that medications such as fenbendazole, mebendazole, and ivermectin may disrupt critical cancer cell processes including energy production, cellular division, and survival mechanisms. These compounds belong to the benzimidazole drug class and are both inexpensive and readily accessible, adding to their growing popularity.
Some integrative oncologists have started investigating these treatments with carefully selected patients, documenting instances of surprising cancer remissions. Nevertheless, none of these anti-parasitic medications have received FDA approval for cancer therapy, and rigorous clinical trials remain absent from the scientific literature.
Despite the compelling nature of these accounts and encouraging preliminary research findings, medical experts strongly advise that patients seek guidance from their healthcare providers.
